» Articles » PMID: 37997550

Association of Five Diet Scores with Severe NAFLD Incidence: A Prospective Study from UK Biobank

Abstract

Aim: This study aimed to contrast the associations of five common diet scores with severe non-alcoholic fatty liver disease (NAFLD) incidence.

Materials And Methods: In total, 162 999 UK Biobank participants were included in this prospective population-based study. Five international diet scores were included: the 14-Item Mediterranean Diet Adherence Screener (MEDAS-14), the Recommended Food Score (RFS), the Healthy Diet Indicator (HDI), the Mediterranean Diet Score and the Mediterranean-DASH Intervention for Neurodegenerative Delay score. As each score has different measurements and scales, all scores were standardized and categorized into quartiles. Cox proportional hazard models adjusted for confounder factors investigated associations between the standardized quartiles and severe NAFLD incidence.

Results: Over a median follow-up of 10.2 years, 1370 participants were diagnosed with severe NAFLD. When the analyses were fully adjusted, participants in quartile 4 using the MEDAS-14 and RFS scores, as well as those in quartiles 2 and 3 using the HDI score, had a significantly lower risk of severe incident NAFLD compared with those in quartile 1. The lowest risk was observed in quartile 4 for the MEDAS-14 score [hazard ratio (HR): 0.76 (95% confidence interval (CI): 0.62-0.94)] and the RFS score [HR: 0.82 (95% CI: 0.69-0.96)] and as well as in quartile 2 in the HDI score [HR: 0.80 (95% CI: 0.70-0.91)].

Conclusion: MEDAS-14, RFS and HDI scores were the strongest diet score predictors of severe NAFLD. A healthy diet might protect against NAFLD development irrespective of the specific approach used to assess diet. However, following these score recommendations could represent optimal dietary approaches to mitigate NAFLD risk.

Citing Articles

A flavonoid-rich diet is associated with lower risk and improved imaging biomarkers of nonalcoholic fatty liver disease: a prospective cohort study.

Bell W, Jennings A, Thompson A, Bondonno N, Tresserra-Rimbau A, Kuhn T Am J Clin Nutr. 2024; 120(6):1325-1334.

PMID: 39341459 PMC: 11619783. DOI: 10.1016/j.ajcnut.2024.09.022.


Effective roles of exercise and diet adherence in non-alcoholic fatty liver disease.

Zhu W World J Gastroenterol. 2024; 30(29):3456-3460.

PMID: 39156504 PMC: 11326086. DOI: 10.3748/wjg.v30.i29.3456.


Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department.

Miano N, Todaro G, Di Marco M, Scilletta S, Bosco G, Di Giacomo Barbagallo F Nutrients. 2024; 16(12).

PMID: 38931279 PMC: 11206738. DOI: 10.3390/nu16121925.


Adherence to a Mediterranean diet is associated with a lower risk of diabetic kidney disease among individuals with hyperglycemia: a prospective cohort study.

Qu C, Zhao J, Lai J, Wu X, Huang P, Zhu T BMC Med. 2024; 22(1):224.

PMID: 38831391 PMC: 11149182. DOI: 10.1186/s12916-024-03455-3.


Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank.

Petermann-Rocha F, Carrasco-Marin F, Boonpor J, Parra-Soto S, Shannon O, Malcomson F Diabetes Obes Metab. 2023; 26(3):860-870.

PMID: 37997550 PMC: 11497349. DOI: 10.1111/dom.15378.

References
1.
Liu B, Young H, Crowe F, Benson V, Spencer E, Key T . Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies. Public Health Nutr. 2011; 14(11):1998-2005. DOI: 10.1017/S1368980011000942. View

2.
Ma J, Hennein R, Liu C, Long M, Hoffmann U, Jacques P . Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018; 155(1):107-117. PMC: 6035111. DOI: 10.1053/j.gastro.2018.03.038. View

3.
Dolce A, Della Torre S . Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution. Nutrients. 2023; 15(10). PMC: 10222590. DOI: 10.3390/nu15102335. View

4.
Schneider K, Schneider C . A new era for steatotic liver disease: Evaluating the novel nomenclature in the UK Biobank. J Hepatol. 2023; 80(2):e58-e60. DOI: 10.1016/j.jhep.2023.07.007. View

5.
Fry A, Littlejohns T, Sudlow C, Doherty N, Adamska L, Sprosen T . Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017; 186(9):1026-1034. PMC: 5860371. DOI: 10.1093/aje/kwx246. View